Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine for intermittent preventive treatment of malaria in pregnancy
PACTR2010020001429343Unknown
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Trial of mefloquine and sulfadoxine + pyrimethamine in malaria (3 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Prevalence of low birth weight. Status: unknown.
02
Drugs
mefloquinesulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR2010020001429343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2010020001429343.